Mark D DeBoer1, Stephanie L Filipp2, Solomon K Musani3, Mario Sims3, Mark D Okusa4, Matthew Gurka2. 1. Department of Pediatrics, Division of Pediatric Endocrinology, University of Virginia, Charlottesville, Virginia, USA. 2. Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida, USA. 3. Department of Medicine, Jackson Heart Study, University of Mississippi Medical Center, Jackson, Mississippi, USA. 4. Department of Medicine, Division of Nephrology, University of Virginia, Charlottesville, Virginia, USA.
Abstract
BACKGROUND/AIMS: The metabolic syndrome (MetS), as assessed using dichotomous criteria, is associated with increased risk of future chronic kidney disease (CKD), though this relationship is unclear among African Americans, who have lower risk for MetS but higher risk for CKD. METHODS: We performed logistic regression using a sex- and race-specific MetS-severity z-score to assess risk of incident CKD among 2,627 African-American participants of the Jackson Heart Study, assessed at baseline and 8 years later. Based on quartile of baseline MetS severity, we further assessed prevalence of being in the lowest quartile of baseline GFR, the lowest quartile of relative GFR at follow-up, microalbuminuria and incident CKD. RESULTS: Higher MetS-severity was associated with higher prevalence of GFR in the lowest quartile at baseline among males and females. Among African-American females but not males, higher baseline MetS-severity was associated with a higher prevalence of baseline elevations in microabuminuria (p<0.01), steep decline in GFR (p<0.001) and a higher incidence of CKD (p<0.0001). Women in increasing quartiles of baseline MetS-severity exhibited a linear trend toward higher odds of future CKD (p<0.05), with those in the 4th quartile of MetS-severity (compared to the 1st) having an odds ratio of 2.47 (95% confidence interval 1.13, 5.37); no such relationship was seen among men (p value for trend 0.49). CONCLUSION: MetS-severity exhibited sex-based interactions regarding risk for future GFR deterioration and CKD, with increasing risk in women but not men. These data may have implications for triggering CKD screening among African-American women with higher degrees of MetS-severity.
BACKGROUND/AIMS: The metabolic syndrome (MetS), as assessed using dichotomous criteria, is associated with increased risk of future chronic kidney disease (CKD), though this relationship is unclear among African Americans, who have lower risk for MetS but higher risk for CKD. METHODS: We performed logistic regression using a sex- and race-specific MetS-severity z-score to assess risk of incident CKD among 2,627 African-American participants of the Jackson Heart Study, assessed at baseline and 8 years later. Based on quartile of baseline MetS severity, we further assessed prevalence of being in the lowest quartile of baseline GFR, the lowest quartile of relative GFR at follow-up, microalbuminuria and incident CKD. RESULTS: Higher MetS-severity was associated with higher prevalence of GFR in the lowest quartile at baseline among males and females. Among African-American females but not males, higher baseline MetS-severity was associated with a higher prevalence of baseline elevations in microabuminuria (p<0.01), steep decline in GFR (p<0.001) and a higher incidence of CKD (p<0.0001). Women in increasing quartiles of baseline MetS-severity exhibited a linear trend toward higher odds of future CKD (p<0.05), with those in the 4th quartile of MetS-severity (compared to the 1st) having an odds ratio of 2.47 (95% confidence interval 1.13, 5.37); no such relationship was seen among men (p value for trend 0.49). CONCLUSION: MetS-severity exhibited sex-based interactions regarding risk for future GFR deterioration and CKD, with increasing risk in women but not men. These data may have implications for triggering CKD screening among African-American women with higher degrees of MetS-severity.
Authors: G Targher; L Bertolini; M Chonchol; S Rodella; G Zoppini; G Lippi; L Zenari; E Bonora Journal: Diabetologia Date: 2010-04-06 Impact factor: 10.122
Authors: Catherine C Cowie; Keith F Rust; Danita D Byrd-Holt; Edward W Gregg; Earl S Ford; Linda S Geiss; Kathleen E Bainbridge; Judith E Fradkin Journal: Diabetes Care Date: 2010-01-12 Impact factor: 19.112
Authors: Helen L MacLaughlin; Sharlene A Cook; Deepa Kariyawasam; Magnus Roseke; Marcelle van Niekerk; Iain C Macdougall Journal: Am J Kidney Dis Date: 2009-11-17 Impact factor: 8.860
Authors: Arthur M Lee; Jennifer R Charlton; J Bryan Carmody; Matthew J Gurka; Mark D DeBoer Journal: Nephrol Dial Transplant Date: 2017-09-01 Impact factor: 5.992
Authors: Fernando E García-Arroyo; Guillermo Gonzaga-Sánchez; Edilia Tapia; Itzel Muñoz-Jiménez; Lino Manterola-Romero; Horacio Osorio-Alonso; Abraham S Arellano-Buendía; José Pedraza-Chaverri; Carlos A Roncal-Jiménez; Miguel A Lanaspa; Richard J Johnson; Laura Gabriela Sánchez-Lozada Journal: Int J Mol Sci Date: 2021-02-28 Impact factor: 5.923
Authors: Harsha S Nagarajarao; Solomon K Musani; Keith E Cobb; James D Pollard; Leroy L Cooper; Anshul Anugu; Yuichiro Yano; Josiah A Moore; Connie W Tsao; Albert W Dreisbach; Emelia J Benjamin; Naomi M Hamburg; Ramachandran S Vasan; Gary F Mitchell; Ervin R Fox Journal: Kidney Med Date: 2021-07-14